Search
25 articles for “Regulation and Standardization”
-
A Review on the Magical Plant : Shatavari (Asparagus racemosus)
Abstract: Shatavari (Asparagus racemosus) is a revered medicinal herb in Ayurveda, recognized for its diverse health benefits, particularly for women’s health. The chemical makeup, pharmacological characteristics, and therapeutic uses of shatavari are thoroughly examined in this review. Key active compounds include saponins, flavonoids, and phytoestrogens, which contribute to its adaptogenic, antioxidant, and hormone-regulating effects. These properties make Shatavari effective in addressing female reproductive issues, such as infertility, irregular menstrual cycles, and …
Published in Recent Trends in Cosmetics · Vol. 2, Issue 1, 2025 · pp. 32–43 Read article
-
Innovative Approaches to Fake Product Detection: Blockchain and QR Code Synergy
Abstract: For consumers, corporations, and regulatory agencies, the worldwide market's rise of counterfeit goods presents serious issues. Maintaining consumer confidence, guaranteeing product safety, and preserving brand reputation all depend on the ability to identify counterfeit goods. An overview of the different approaches and difficulties associated with spotting counterfeit goods is given in this abstract. First off, the ability to identify sophisticated counterfeit goods is limited by the use of conventional techniques …
Published in International Journal of Radio Frequency Innovations · Vol. 2, Issue 1, 2024 · pp. 21–27 Read article
-
Personalized Therapy Using Drug Delivery Devices
Abstract: The persistent challenge in modern medicine lies in inter-patient heterogeneity, rendering standardized drug dosing protocols suboptimal for many chronic conditions. Traditional pharmacokinetics fail to account for real-time biological fluctuations, leading to cycles of ineffective treatment or dose-limiting toxicity. This paper explores the critical intersection of advanced drug delivery devices (DDDs) and personalized medicine, positioning these technologies as the vital link translating genomic and biological data into tangible, patient- specific interventions. …
Published in Emerging Trends in Personalized Medicines · Vol. 3, Issue 1, 2026 · pp. 53–62 Read article
-
The Mycobiome Frontier – Pre & Post 2020 Status: Integrating Fungal Bioactive Compounds, Probiotics, and Antimicrobial Peptides in Modern Therapeutics and Biotechnology.
Abstract: The fungal kingdom represents an indispensable resource in modern therapeutics and biotechnology, offering a diverse array of bioactive compounds, probiotics, and antimicrobial peptides (AMPs). Functional fungal polysaccharides (FFPs), such as beta-glucans, chitin, and mannans, are centrally involved in modulating the human gut microbiota, providing novel therapeutic avenues for chronic conditions including diabetes, neurodegenerative disorders, and cancer. These compounds act as prebiotics, nourishing beneficial bacteria and enhancing metabolic parameters such as …
Published in International Journal of Fungi · Vol. 3, Issue 1, 2026 · pp. 1–11 Read article
-
Gut Microbial Metabolites in Inflammatory, Metabolic, and Neurologic Disorders.
Abstract: The human gut microbiota transforms dietary and hostderived substrates into a diverse array of metabolites—including shortchain fatty acids (SCFAs), hydrogen sulfide (H₂S), bile acid derivatives, indoles, trimethylamine Noxide (TMAO), branchedchain amino acid (BCAA) derivatives, and lipopolysaccharide (LPS)—that act as key signaling mediators along epithelial, immune, endocrine, and neural axes. These metabolites regulate barrier integrity, energy homeostasis, inflammation, and gut–brain communication and are increasingly implicated in the pathogenesis of inflammatory bowel …
Published in Emerging Trends in Metabolites · Vol. 3, Issue 1, 2026 · pp. 58–64 Read article